10th Circuit Denies Petition For Interlocutory Appeal Of EpiPen Class Certifications

(May 28, 2020, 12:17 PM EDT) -- DENVER — Although five drug companies presented “persuasive arguments,” a 10th Circuit U.S. Court of Appeals panel on May 26 denied a motion for an interlocutory appeal of the certification of...
To view the full article, register now.